Charity Impact Media

Home › Health care

Iowa Prescription Drug Corporation

Also known as Safenetrx

Grimes, IA · EIN 42-1518875 · 501(c)(3) · Publicly supported organization (170(b)(1)(A)(vi))
Latest filing: Form 990 for the fiscal year ending June 30, 2025 (tax year 2024) · View the filing · Correct or respond

Iowa Prescription Drug Corporation reported $29.0 million in revenue and $22.6 million in expenses for the fiscal year ending June 30, 2025. Of every $100 it spent, $99.13 went to program services, $0.87 to management and general costs and $0.00 to fundraising. Its largest source of revenue was contributions and grants: 99.8% of the total. The highest compensation it reported for one person was $207,775 (CEO). 1 person received more than $100,000 in reportable compensation. Revenue rose 234% between FY2020 and FY2025. Source: Form 990, FY2025.

Where $100 of spending went

The fiscal year ending June 30, 2025 · Form 990, Part IX, line 25 · total expenses $23M

For context, the median across 5,634 covered health care charities: $86.19 programs, $13.81 management, $0.00 fundraising (medians computed separately, so they may not sum to $100).

Where $100 of revenue came from

The fiscal year ending June 30, 2025 · Form 990, Part VIII · total revenue $29M

The 990 scorecard · same measures for every charity, no grades

FY2025 filing. Median across 5,634 covered charities in this category, from their latest filings.
MeasureFY2025Median
Program services
Part IX 25(B) ÷ 25(A)
99.1%85.6%
Management & general
Part IX 25(C) ÷ 25(A)
0.9%13.7%
Fundraising
Part IX 25(D) ÷ 25(A)
0.0%0.0%
Fundraising cost per $1 of contributions
Part IX 25(D) ÷ Part VIII 1h
$0.00$0.00
Contributions & grants share of revenue
Part VIII 1h ÷ 12
99.8%1.3%
Government grants share of revenue
Part VIII 1e ÷ 12
2.3%0.1%
Program service revenue share
Part VIII 2g ÷ 12
0.1%93.7%
Highest reported compensation
Part VII-A, columns D–F
$207,775$975,831
Highest compensation as share of expenses
Part VII-A ÷ Part IX 25(A)
0.92%1.34%
People paid over $100,000
Part VII, line 2
127
Net assets, in months of expenses
Part X 33(B) ÷ monthly expenses
12.36.6
Independent voting board members
Part VI 1a–1b
14 of 1488.9%

A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.

What the money paid for, in its own words

FY2025 · Form 990, Part III · the three largest programs by expense
$22M expenses · 99.3% of program spending

Drug donation repository - the purpose of this program is to collect unused prescription medications that accumulate in long-term care and other medical settings. The unused prescription medications are donated to safenetrx, inspected by pharmacists, and distributed to clinics and pharmacies that care for uninsured and underinsured patients that cannot afford needed drug therapies

$162K expenses · 0.7% of program spending

Charitable pharmacy - the purpose of this program is to provide pharmacy services to underserved patients that cannot afford needed drug therapies. The charitable pharmacy fills prescriptions from an inventory of donated medicine received from the drug donation repository

Highest reported compensation

FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here
RoleFrom this orgFrom related orgsOtherTotal
CEO
Officer, 40.00 hrs/week
$207,775$0$0$207,775

1 people received more than $100,000 in reportable compensation from Iowa Prescription Drug Corporation (Part VII, line 2). Compensation of current officers, directors and key employees totaled $208K (Part IX, line 5).

6 years of filings

Form 990, Parts I, VII, IX and X · each row is that year's own filing, linked
RevenueExpenses
$0$10M$20M$30M$40MFY2020FY2021FY2022FY2023FY2024FY2025$29M$23M
FilingRevenueExpensesProgramsNet assetsTop pay
FY2025 ⓘ$29M$23M99.1%$23M$207,775
FY2024 ⓘ$22M$23M99.2%$17M$164,470
FY2023 ⓘ$32M$25M99.2%$18M$159,302
FY2022 ⓘ$21M$11M99.0%$11M$128,006
FY2021 ⓘ$8.9M$8.9M98.9%$1.0M—
FY2020 ⓘ$8.7M$8.7M98.9%$1.0M—

Governance answers, as filed

FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means
  • Voting board members, and how many are independent Part VI, lines 1a–1b14 · 14 independent
  • Audited financial statements Part XII 2bNo
  • Conflict-of-interest policy Part VI 12aYes
  • Whistleblower policy Part VI 13Yes
  • Document retention policy Part VI 14Yes
  • Independent process for top executive pay Part VI 15aYes
  • Board given the 990 before filing Part VI 11aNo
  • Family or business ties among insiders Part VI 2No
  • Aware of a significant diversion of assets Part VI 5No
  • Excess benefit transaction with an insider Part IV 25aNo
  • Loans to or from insiders outstanding Part IV 26No
  • Lobbying, or a 501(h) election in effect Part IV 4No
  • Over $15,000 of professional fundraising services Part IV 18No
  • Over $10,000 of activity outside the U.S. Part IV 14bNo
  • Employees Part I, line 515
  • Volunteers Part I, line 649

Private foundation grants it received

1 private foundation reported grants to Iowa Prescription Drug Corporation totaling $131 on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.

Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.

Correct a figure or respond

Every number above is copied from Iowa Prescription Drug Corporation's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Iowa Prescription Drug Corporation, you can publish a response that is linked from this page.

Similar-sized charities in this cause

All health care charities · Largest charities in Iowa

Questions people ask

How much of Iowa Prescription Drug Corporation's spending goes to programs?

In the fiscal year ending June 30, 2025, Iowa Prescription Drug Corporation reported that 99.1% of its $22.6 million in expenses went to program services, 0.9% to management and general and 0.0% to fundraising (Form 990, Part IX).

How much does Iowa Prescription Drug Corporation pay its top executive?

The largest total compensation Iowa Prescription Drug Corporation reported for one person in the fiscal year ending June 30, 2025 was $207,775, for the role of CEO (Form 990, Part VII, including compensation from related organizations and other compensation).

Where does Iowa Prescription Drug Corporation get its money?

Of $29.0 million in revenue in the fiscal year ending June 30, 2025, 99.8% came from contributions and grants (including 2.3% from government grants) and 0.1% from program service revenue (Form 990, Part VIII).

Is Iowa Prescription Drug Corporation a registered charity?

The IRS lists EIN 42-1518875 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.

Sources

  • FY2025: Form 990 for the fiscal year ending June 30, 2025, object 202601339349308715 · read the filing · XML
  • FY2024: Form 990 for the fiscal year ending June 30, 2024, object 202521359349315132 · read the filing
  • FY2023: Form 990 for the fiscal year ending June 30, 2023, object 202401369349316830 · read the filing
  • FY2022: Form 990 for the fiscal year ending June 30, 2022, object 202331359349319813 · read the filing
  • FY2021: Form 990 for the fiscal year ending June 30, 2021, object 202231369349317528 · read the filing
  • FY2020: Form 990 for the fiscal year ending June 30, 2020, object 202131379349311398 · read the filing

All filings for EIN 42-1518875: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.